|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
218,850,000 |
Market
Cap: |
39.94(B) |
Last
Volume: |
90,505,923 |
Avg
Vol: |
10,797,637 |
52
Week Range: |
$182.5 - $182.5 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Nader Francois |
Director |
|
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,921) |
0 |
|
- |
|
Orloff John J |
EVP, Research & Development |
|
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(146,511) |
0 |
|
- |
|
Bazarko Daniel |
SVP, Controller, CAO |
|
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(60,207) |
0 |
|
- |
|
Hantson Ludwig |
CEO |
|
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(580,809) |
9,098 |
|
- |
|
Reinsdorf Judith A |
Director |
|
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(14,150) |
0 |
|
- |
|
Franchini Indrani Lall |
EVP, Chief Compliance Officer |
|
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(116,075) |
0 |
|
- |
|
Goff Brian |
EVP & Chief Commercial Officer |
|
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(150,832) |
0 |
|
- |
|
Sarin Aradhana |
EVP, CFO |
|
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(120,253) |
0 |
|
- |
|
Friedman Paul A |
Director |
|
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,840) |
0 |
|
- |
|
Mollen John T |
Director |
|
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,336) |
0 |
|
- |
|
Rummelt Andreas |
Director |
|
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(28,109) |
0 |
|
- |
|
Carino Tanisha |
EVP & CCAO |
|
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(59,226) |
0 |
|
- |
|
Coughlin Christopher J |
Director |
|
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(42,347) |
0 |
|
- |
|
Brennan David R |
Director |
|
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,873) |
0 |
|
- |
|
Chiniara Ellen |
EVP & Chief Legal Officer |
|
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(116,850) |
0 |
|
- |
|
Dunsire Deborah |
Director |
|
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(14,629) |
0 |
|
- |
|
Orloff John J |
EVP, Research & Development |
|
2021-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
60,144 |
146,511 |
|
- |
|
Carino Tanisha |
EVP & CCAO |
|
2021-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
25,813 |
59,226 |
|
- |
|
Bazarko Daniel |
SVP, Controller, CAO |
|
2021-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
21,708 |
60,207 |
|
- |
|
Goff Brian |
EVP & Chief Commercial Officer |
|
2021-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
60,144 |
150,832 |
|
- |
|
Sarin Aradhana |
EVP, CFO |
|
2021-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
56,313 |
120,253 |
|
- |
|
Franchini Indrani Lall |
EVP, Chief Compliance Officer |
|
2021-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
52,625 |
116,075 |
|
- |
|
Chiniara Ellen |
EVP & Chief Legal Officer |
|
2021-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
54,469 |
116,850 |
|
- |
|
Hantson Ludwig |
CEO |
|
2021-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
240,741 |
589,907 |
|
- |
|
Orloff John J |
EVP, Research & Development |
|
2021-06-08 |
4 |
D |
$177.00 |
$346,389 |
D/D |
(1,957) |
86,367 |
|
- |
|
609 Records found
|
|
Page 1 of 25 |
|
|